Correa, M Elvira P
Cheng, Karis Kin Fong
Chiang, Karen
Kandwal, Abhishek
Loprinzi, Charles L
Mori, Takehiko
Potting, Carin
Rouleau, Tanya
Toro, Juan J
Ranna, Vinisha
Vaddi, Anusha
Peterson, Douglas E
Bossi, Paolo
Lalla, Rajesh V
Elad, Sharon
Article History
Received: 29 October 2019
Accepted: 27 November 2019
First Online: 14 December 2019
Compliance with ethical standards
:
: Per the MASCC Guidelines Policy, employees of commercial entities were not eligible to serve on this MASCC Guidelines Panel. All authors completed a Conflict of Interest disclosure form and conflicts are disclosed in the guideline’s publications.The authors disclose no conflict of interest (MEPC, KC, AK, TM, CP, TR, JJT, VR, AV, DEP). PB has served an advisory role for Galera Therapeutics, AstraZeneca, Helsinn, and Kyowa Kyrin and received grants from Merck, Kyowa Kyrin, and Roche.CLL reports personal fees from PledPharma, Disarm Therapeutics, Asahi Kasei, Metys Pharmaceuticals, and OnQuality, outside the submitted work.RVL reports personal fees from Colgate Oral Pharmaceuticals, grants and personal fees from Galera Therapeutics, personal fees from Ingalfarma, other from Logic Biosciences, personal fees from Monopar Therapeutics, personal fees from Mundipharma, grants from Novartis, grants from Oragenics, grants and personal fees from Sucampo Pharma, personal fees from Alira Health, outside the submitted work.SE reports no conflict in regard to mucositis and consulting to Falk Pharma outside the submitted work.
: This article does not contain any studies with human participants or animals performed by any of the authors.